Zhuxiao Gu1,2, Xinhong Xiong3, Xiang Chen1
1Department of Cardiology, Cardiovascular Disease Center, Institute of Clinical Medicine, Jiangsu Key Laboratory For Cardiovascular Information and Health Engineering Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers repurposed liver-targeting lipid nanoparticles (LNPs) for lung-specific messenger RNA (mRNA) delivery. This novel ligand-mediated reprogramming enhances mRNA translation in the lungs, advancing gene therapy applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: